It is unclear whether the findings presented in our study have clinical relevance for risk of prostate cancer, since PSA ≥ 4.0 ng/ mL has a relatively low sensitivity but remains the most common threshold for recommending further imaging or a biopsy. Here, KLK3 is linked to prostate cancer.